Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045006
Filing Date
2024-11-04
Accepted
2024-11-04 16:14:11
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20240930.htm   iXBRL 10-Q 828207
2 EX-10.1 ex101foghornemploymentagre.htm EX-10.1 49427
3 EX-31.1 fhtx-20240930xex311.htm EX-31.1 10252
4 EX-31.2 fhtx-20240930xex312.htm EX-31.2 10234
5 EX-32.1 fhtx-20240930xex321.htm EX-32.1 4301
6 EX-32.2 fhtx-20240930xex322.htm EX-32.2 4286
12 GRAPHIC image_0.jpg GRAPHIC 64218
  Complete submission text file 0001628280-24-045006.txt   4649427

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20240930.xsd EX-101.SCH 32589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20240930_cal.xml EX-101.CAL 51605
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20240930_def.xml EX-101.DEF 136108
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20240930_lab.xml EX-101.LAB 470326
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20240930_pre.xml EX-101.PRE 303645
62 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20240930_htm.xml XML 498354
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 241423709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)